Abstract
We found that an induction immunotherapy regimen consisting of rabbit anti-thymocyte globulin (Thymoglobulin) and the monoclonal antibody to CD20 rituximab (Rituxan) promoted long-term islet allograft survival in cynomolgus macaques maintained on rapamycin monotherapy. B lymphocyte reconstitution after rituximab-mediated depletion was characterized by a preponderance of immature and transitional cells, whose persistence was associated with long-term islet allograft survival. Development of donor-specific alloantibodies was abrogated only in the setting of continued rapamycin monotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1295-1298 |
| Number of pages | 4 |
| Journal | Nature Medicine |
| Volume | 13 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2007 |
Fingerprint
Dive into the research topics of 'B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver